Morgan Stanley Maintains BioAge Labs(BIOA.US) With Buy Rating, Maintains Target Price $40
Morgan Stanley Keeps Their Buy Rating on BioAge Labs, Inc. (BIOA)
Citi Maintains BioAge Labs(BIOA.US) With Buy Rating, Maintains Target Price $45
Citi Initiates BioAge Labs(BIOA.US) With Buy Rating, Announces Target Price $45
Bioage Labs Analyst Ratings
Jefferies Initiates BioAge Labs(BIOA.US) With Buy Rating, Announces Target Price $42
Morgan Stanley Initiates BioAge Labs(BIOA.US) With Buy Rating, Announces Target Price $40
BioAge Labs Initiated With an Overweight at Morgan Stanley
BioAge Labs Initiated With a Buy at Jefferies
BioAge Labs, Inc.: Promising Developments and Strategic Partnerships Lead to Buy Rating
No Data
No Data